| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 146, Issue 8 2763-2770, Copyright © 1991 by American Association of Immunologists
ARTICLES |
PM Kaye, AJ Curry and JM Blackwell
Dept. of Medical Parasitology, London School of Hygiene and Tropical Medicine, UK.
Recent studies with models of cutaneous leishmaniasis have provoked much interest in the role of CD4+ T cell subsets in determining the outcome of infectious disease. In Leishmania major infections, cure vs progressive disease correlates with the expansion of Th1-like or Th2- like CD4+ populations, respectively. We have investigated whether similar responses are associated with the differential patterns of infection seen in models of visceral leishmaniasis, caused by L. donovani. Splenic lymphocytes from infected Lsh congenic C57BL/10 (Lshs;H-2b) and B10.L-Lshr (Lshr;H-2b) mice and MHC congenic non-curing B10.D2/n (Lshs;H-2d) mice were examined for the production of cytokines representative of these CD4+ populations (IL-2, IL-3, IL-4, IL-5, and IFN-gamma). In all three strains examined, there was no evidence for the production of Th2-restricted cytokines. In addition, levels of serum IgE were depressed during the early phase of infection, indicative of in vivo IFN-gamma production. In the non-curing B10.D2/n strain, late phase of infection was associated with the decreased ability to produce cytokines in response to Ag and not with the production of IL-4 or IL-5 in response to Ag or mitogen. Serum IgE levels were also not raised above levels seen in uninfected controls. C57BL/10 mice were vaccinated with SDS-PAGE fractionated amastigote Ag bound to nitrocellulose and cytokine levels determined at various times after infection. The protocol used for vaccination was able to induce significant modulation of the course of infection in this strain and it was clear that IFN-gamma production in vitro provided an excellent correlate of rate of cure. Occasional individuals produced low levels of IL-5 in culture in response to parasite Ag, but this did not correlate with disease progression. Together, these data suggest that over-expansion of Th2-type cells and production of their specific cytokines (IL-4 and IL-5) is not a contributing factor to the variable long term course of L. donovani infection in these strains of mice.
This article has been cited by other articles:
|
|
 |
|
  C. F. Anderson, R. Lira, S. Kamhawi, Y. Belkaid, T. A. Wynn, and D. Sacks IL-10 and TGF-{beta} Control the Establishment of Persistent and Transmissible Infections Produced by Leishmania tropica in C57BL/6 Mice J. Immunol., March 15, 2008; 180(6): 4090 - 4097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maroof and P. M. Kaye Temporal Regulation of Interleukin-12p70 (IL-12p70) and IL-12-Related Cytokines in Splenic Dendritic Cell Subsets during Leishmania donovani Infection Infect. Immun., January 1, 2008; 76(1): 239 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, S. Bhaumik, A. K. Haldar, K. Naskar, T. De, S. K. Dana, P. Walden, and S. Roy Hybrid Cell Vaccination Resolves Leishmania donovani Infection by Eliciting a Strong CD8+ Cytotoxic T-Lymphocyte Response with Concomitant Suppression of Interleukin-10 (IL-10) but Not IL-4 or IL-13 Infect. Immun., December 1, 2007; 75(12): 5956 - 5966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Silvestre, A. Cordeiro-Da-Silva, N. Santarem, B. Vergnes, D. Sereno, and A. Ouaissi SIR2-Deficient Leishmania infantum Induces a Defined IFN-{gamma}/IL-10 Pattern That Correlates with Protection J. Immunol., September 1, 2007; 179(5): 3161 - 3170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Hassan, Y. Zhang, C. R. Engwerda, P. M. Kaye, H. Sharp, and Q. D. Bickle The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovani Am. J. Pathol., September 1, 2006; 169(3): 943 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Basu, S. Bhaumik, J. M. Basu, K. Naskar, T. De, and S. Roy Kinetoplastid Membrane Protein-11 DNA Vaccination Induces Complete Protection against Both Pentavalent Antimonial-Sensitive and -Resistant Strains of Leishmania donovani That Correlates with Inducible Nitric Oxide Synthase Activity and IL-4 Generation: Evidence for Mixed Th1- and Th2-Like Responses in Visceral Leishmaniasis J. Immunol., June 1, 2005; 174(11): 7160 - 7171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. VANLOUBBEECK and D. E. JONES The Immunology of Leishmania Infection and the Implications for Vaccine Development Ann. N.Y. Acad. Sci., October 1, 2004; 1026(1): 267 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. F. Vanloubbeeck, A. E. Ramer, F. Jie, and D. E. Jones CD4+ Th1 Cells Induced by Dendritic Cell-Based Immunotherapy in Mice Chronically Infected with Leishmania amazonensis Do Not Promote Healing Infect. Immun., August 1, 2004; 72(8): 4455 - 4463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kropf, M. A. Freudenberg, M. Modolell, H. P. Price, S. Herath, S. Antoniazi, C. Galanos, D. F. Smith, and I. Muller Toll-Like Receptor 4 Contributes to Efficient Control of Infection with the Protozoan Parasite Leishmania major Infect. Immun., April 1, 2004; 72(4): 1920 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. E. Rodriguez, H. K. Chang, and M. E. Wilson Novel Program of Macrophage Gene Expression Induced by Phagocytosis of Leishmania chagasi Infect. Immun., April 1, 2004; 72(4): 2111 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ravindran, K. Anam, B. C. Bairagi, B. Saha, N. Pramanik, S. K. Guha, R. P. Goswami, D. Banerjee, and N. Ali Characterization of Immunoglobulin G and Its Subclass Response to Indian Kala-Azar Infection before and after Chemotherapy Infect. Immun., February 1, 2004; 72(2): 863 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Meier, M. Svensson, and P. M. Kaye Leishmania-Induced Inhibition of Macrophage Antigen Presentation Analyzed at the Single-Cell Level J. Immunol., December 15, 2003; 171(12): 6706 - 6713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. M. Padigel, J. Alexander, and J. P. Farrell The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania mexicana and Leishmania amazonensis J. Immunol., October 1, 2003; 171(7): 3705 - 3710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Stager, J. Alexander, K. C. Carter, F. Brombacher, and P. M. Kaye Both Interleukin-4 (IL-4) and IL-4 Receptor {alpha} Signaling Contribute to the Development of Hepatic Granulomas with Optimal Antileishmanial Activity Infect. Immun., August 1, 2003; 71(8): 4804 - 4807. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. F. Coelho, C. A. P. Tavares, F. A. A. Carvalho, K. F. Chaves, K. N. Teixeira, R. C. Rodrigues, H. Charest, G. Matlashewski, R. T. Gazzinelli, and A. P. Fernandes Immune Responses Induced by the Leishmania (Leishmania) donovani A2 Antigen, but Not by the LACK Antigen, Are Protective against Experimental Leishmania (Leishmania) amazonensis Infection Infect. Immun., July 1, 2003; 71(7): 3988 - 3994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ahmed, M. Colmenares, L. Soong, K. Goldsmith-Pestana, L. Munstermann, R. Molina, and D. McMahon-Pratt Intradermal Infection Model for Pathogenesis and Vaccine Studies of Murine Visceral Leishmaniasis Infect. Immun., January 1, 2003; 71(1): 401 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Afrin, R. Rajesh, K. Anam, M. Gopinath, S. Pal, and N. Ali Characterization of Leishmania donovani Antigens Encapsulated in Liposomes That Induce Protective Immunity in BALB/c Mice Infect. Immun., December 1, 2002; 70(12): 6697 - 6706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cordeiro-da-Silva, M. C. Borges, E. Guilvard, and A. Ouaissi Dual Role of the Leishmania major Ribosomal Protein S3a Homologue in Regulation of T- and B-Cell Activation Infect. Immun., November 1, 2001; 69(11): 6588 - 6596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Melby, J. Yang, W. Zhao, L. E. Perez, and J. Cheng Leishmania donovani p36(LACK) DNA Vaccine Is Highly Immunogenic but Not Protective against Experimental Visceral Leishmaniasis Infect. Immun., August 1, 2001; 69(8): 4719 - 4725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Streit, T. J. Recker, F. G. Filho, S. M. Beverley, and M. E. Wilson Protective Immunity Against the Protozoan Leishmania chagasi Is Induced by Subclinical Cutaneous Infection with Virulent But Not Avirulent Organisms J. Immunol., February 1, 2001; 166(3): 1921 - 1929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Kane and D. M. Mosser The Role of IL-10 in Promoting Disease Progression in Leishmaniasis J. Immunol., January 15, 2001; 166(2): 1141 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Melby, G. B. Ogden, H. A. Flores, W. Zhao, C. Geldmacher, N. M. Biediger, S. K. Ahuja, J. Uranga, and M. Melendez Identification of Vaccine Candidates for Experimental Visceral Leishmaniasis by Immunization with Sequential Fractions of a cDNA Expression Library Infect. Immun., October 1, 2000; 68(10): 5595 - 5602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Gomes, V. Barreto-de-Souza, and G. A. DosReis Early in vitro priming of distinct Th cell subsets determines polarized growth of visceralizing Leishmania in macrophages Int. Immunol., September 1, 2000; 12(9): 1227 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. J. Cotterell, C. R. Engwerda, and P. M. Kaye Enhanced Hematopoietic Activity Accompanies Parasite Expansion in the Spleen and Bone Marrow of Mice Infected with Leishmania donovani Infect. Immun., April 1, 2000; 68(4): 1840 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Gomes, C. R. Gattass, V. Barreto-de-Souza, M. E. Wilson, and G. A. DosReis TGF-{beta} Mediates CTLA-4 Suppression of Cellular Immunity in Murine Kalaazar J. Immunol., February 15, 2000; 164(4): 2001 - 2008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Alexander, A. Satoskar, and D. Russell Leishmania species: models of intracellular parasitism J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002. [Abstract] [PDF]
|
|
|
|
|
|
M. E. Wilson, B. M. Young, B. L. Davidson, K. A. Mente, and S. E. McGowan The Importance of TGF-{beta} in Murine Visceral Leishmaniasis J. Immunol., December 1, 1998; 161(11): 6148 - 6155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Murphy, S. E. J. Cotterell, P. M. A. Gorak, C. R. Engwerda, and P. M. Kaye Blockade of CTLA-4 Enhances Host Resistance to the Intracellular Pathogen, Leishmania donovani J. Immunol., October 15, 1998; 161(8): 4153 - 4160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Melby, V. V. Tryon, B. Chandrasekar, and G. L. Freeman Cloning of Syrian Hamster (Mesocricetus auratus) Cytokine cDNAs and Analysis of Cytokine mRNA Expression in Experimental Visceral Leishmaniasis Infect. Immun., May 1, 1998; 66(5): 2135 - 2142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Melby, Y.-Z. Yang, J. Cheng, and W. Zhao Regional Differences in the Cellular Immune Response to Experimental Cutaneous or Visceral Infection with Leishmania donovani Infect. Immun., January 1, 1998; 66(1): 18 - 27. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
